French private equity group Astorg has agreed a buyout of drug contract development and manufacturing business CordenPharma in a deal reportedly worth more than €2.5bn. The post Astorg agrees CordenPharma carve-out in deal said to exceed
Healthcare-focused buyout house Lead Capital Partners has hired former Gen Cap America senior exec Lamar Stanley as a director. The post Healthcare-focused Lead Capital Partners brings in ex-Gen Cap America exec Stanley as director first
Enhanced Healthcare Partners has promoted Brandon Einstein to partner after seven years with the firm. The post Enhanced Healthcare Partners promotes Einstein to partner first appeared on AltAssets Private Equity News.
Global buyout giant Clayton Dubilier & Rice is said to be in advanced talks to buy the hospice, palliative and personal care business from Humana Inc at a $3bn valuation. The post CD&R said to
Global buyout giant KKR has led a consortium to file a record $14.8bn bid for Australian hospital operator Ramsay Health Care, making it potentially the biggest private equity-backed buyout deal for an Australian company. The
Healthcare-focused buyout house ArchiMed has agreed to take medical device maker Natus Medical private for $1.2bn. The post ArchiMed to take medical device maker Natus Medical private for $1.2bn first appeared on AltAssets Private Equity News.
Buyout majors GTCR and CD&R have expressed interest in acquiring US medical device manufacturer Merit Medical Systems, Reuters reported quoting people familiar with the matter. The post GTCR, CD&R said to be after US medical
Healthcare-focused private equity house Havencrest Capital Management has beaten its target for its second fund thanks to strong performance from its debut investment vehicle. The post Strong Fund I performance helps healthcare-focused Havencrest beat $300m
Blue Wolf Capital Partners has hit a $1.1bn hard cap final close for its fifth flagship fund - more than double the amount it gathered for Fund IV. The post Blue Wolf surges to $1.1bn
US private equity major Thomas H Lee Partners has agreed to buy a majority stake in Warburg Pincus' healthcare data and documentation software specialist Intelligent Medical Objects. The post Thomas H Lee Partners agrees to
European biotech investor Kurma Partners is well on the way to its €250m goal for its Growth Opportunities fund thanks to a sizeable first close. The post European biotech backer Kurma Ventures seals big first
Chinese healthcare private equity house CBC Group has beaten its target for its latest fund by raising close to $1.6bn. The post Chinese healthcare PE house CBC Group beats Fund V target to raise almost
Global buyout giant Blackstone has made a trio of senior appointments targeting healthcare dealmaking, including for its newly-created global head of healthcare investing role. The post Blackstone names Jagannath to new global healthcare investing role,
Pan-European focused fund house Kartesia has made a significant funding into Darwin Group. The post Kartesia invests into NHS main contractor Darwin Group first appeared on AltAssets Private Equity News.
Pan European buyout house IK Partners has agreed to tap its €1.2bn Small Cap III Fund to invest in French e-health business Sofia Développement Group. The firm joins existing shareholders Extens, Capital Croissance and Bpifrance as
Spanish alternative asset manager Clave has launched an €80m fundraise targeting early-stage technology transfer projects linked to knowledge-generating centers in the healthcare field. The post Spain’s Clave launches €80m-targeting fundraise aimed at healthcare tech knowledge first
Healthcare services-focused private equity firm InTandem Capital has closed InTandem Capital Opportunities Fund on its $225m hard cap. The post InTandem closes $225m opportunities fund to provide capital for future Fund II investments first appeared
Global buyout giant KKR has closed KKR Health Care Strategic Growth Fund II on $4bn, just shy of tripling the size of its $1.45bn predecessor fund I which was closed in 2017. The post KKR
New Mountain Capital has exited healthcare provider revenue management system Cloudmed to Nasdaq-listed RI RCM in an all stock transaction which valued the company at $4.1bn, including $857m of net debt. The post R1 RCM
UK private equity player Maven Equity has sold its stake in Healthpoint with a 3.1x return, marking the second exit in the week. The post Maven Equity sells Healthpoint at 3.1x return, second exit in
